Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,659.20
(
0.25%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.35
(
-0.33%
)
Bitcoin
79,634.71
(
0.44%
)
News Focus
News Focus
Post# of 826044
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

flipper44

Send PM Follow Ignore
Followers 308
Posts 37397
Boards Moderated 1
Alias Born 11/14/2013

flipper44

Member Level

Re: dstock07734 post# 719988

Saturday, 09/14/2024 1:08:22 AM

Saturday, September 14, 2024 1:08:22 AM

Post# of 826044
Actually, the molecules actually have three dimensional anomalies from one another. Clearly Merck was better at designing the lion’s share of the CI trials, but hard to say Keytruda’s differences otherwise make it better than Opdivo. Maybe Amgen will solve the mystery regarding why Keytruda seems to win out a little more often.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News